Several other large investors have also recently made changes to their positions in DVA.
DaVita's chief executive, Kent J. Thiry, described the medical group's most recent quarterly results as "extremely disappointing" but on Wednesday, he said he was proud of its accomplishments and "The combination of DaVita Medical Group and Optum should lead to even higher levels of performance". UNH is up up 1%, but only on 2 shares. First Republic Invest Inc owns 5,664 shares. In related news, Director William L. Roper sold 12,994 shares of the business's stock in a transaction on Thursday, May 4th. Cibc World holds 0.02% in DaVita Inc. Glenmede Trust Na owns 364,124 shares or 0.12% of their United States portfolio. Over the past month the firm's stock is 1.70%, 6.11% for the last quarter, -4.87% for the past six-months and -4.96% for the previous year. Institutional investors own 85.32% of the company's stock. Thus, the HHS rule clarifying the issue, and perhaps more significantly, activity by the Department of Justice looking into activity by DaVita and Fresenius on the same topic. The company has a debt-to-equity ratio of 1.79, a current ratio of 1.40 and a quick ratio of 1.35. Usa Finance Portformulas invested 0.09% in DaVita Inc. On Monday, June 26 the stock rating was maintained by RBC Capital Markets with "Hold". 157.19 million shares or 0.09% more from 157.04 million shares in 2017Q1 were reported. The firm had revenue of $3.92 billion during the quarter, compared to analysts' expectations of $3.91 billion. They expect $0.91 EPS, down 7.14 % or $0.07 from last year's $0.98 per share.
Analysts await DaVita Inc.
DaVita was valued at $11.2 billion as of Tuesday afternoon. The company has market cap of $12.55 billion. Following the completion of the sale, the director now owns 34,719 shares of the company's stock, valued at $2,284,510.20. (NYSE:DVA) or 22,006 shares. The stock has "Hold" rating by Robert W. Baird on Sunday, October 15. Citigroup initiated the stock with "Neutral" rating in Tuesday, September 6 report. The company was maintained on Wednesday, November 8 by RBC Capital Markets. Finally, Wolfe Research raised DaVita HealthCare Partners from a "market perform" rating to an "outperform" rating in a research report on Monday, October 23rd. SunTrust has "Hold" rating and $57.0 target. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of worldwide trademark and copyright law. (NYSE:DVA) for 98,011 shares.
Minnetonka, Minn. -based UnitedHealth's deal will add DaVita Medical Group's almost 300 primary and specialty care clinics to its Optum segment, as well as some urgent care and outpatient surgery centers. The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its worldwide operations, and its corporate administrative support.